Pazopanib hydrochloride
Pazopanib hydrochloride | |
---|---|
Term | Pazopanib hydrochloride |
Short definition | Pazopanib hydrochloride - (pronounced) (puh-ZOH-puh-nib HY-droh-KLOR-ide) A drug used to treat adults with advanced renal cell carcinoma (a type of kidney cancer) or advanced soft tissue sarcoma who have already been treated with other anticancer medicines. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Pazopanib hydrochloride - (pronounced) (puh-ZOH-puh-nib HY-droh-KLOR-ide) A drug used to treat adults with advanced renal cell carcinoma (a type of kidney cancer) or advanced soft tissue sarcoma who have already been treated with other anticancer medicines. It is also being studied in the treatment of other types of cancer. Pazopanib hydrochloride blocks certain proteins that can prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of anti-angiogenesis agent. Also called GW786034 and Votrient
External links
- Medical encyclopedia article on Pazopanib hydrochloride
- Wikipedia's article - Pazopanib hydrochloride
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski